Page 16 - Nasdaq Vktx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq vktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Vktx Today - Breaking & Trending Today

Oppenheimer Increases Viking Therapeutics (NASDAQ:VKTX) Price Target to $30.00

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its price objective hoisted by Oppenheimer from $20.00 to $30.00 in a report published on Tuesday morning, The Fly reports. They currently have an outperform rating on the biotechnology company’s stock. Other analysts also recently issued reports about the stock. StockNews.com assumed coverage on shares of Viking Therapeutics […] ....

San Diego , United States , Marianna Mancini , Stifel Nicolaus , Raymond James , Michaela Dinerman , Asset Management Corp , Financial Insights Inc , Maxim Group , Cornerstone Capital Inc , Connor Clark Lunn Investment Management Ltd , Therapeutics Inc , Viking Therapeutics , Get Rating , Moderate Buy , Capital Management , Management Corp , Connor Clark , Lunn Investment Management , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Boost Price Target , Oppenheimer Holdings Inc ,

Viking Therapeutics (NASDAQ:VKTX) Given New $25.00 Price Target at Maxim Group

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price upped by Maxim Group from $15.00 to $25.00 in a report released on Tuesday morning, Marketbeat.com reports. Maxim Group currently has a buy rating on the biotechnology company’s stock. Several other brokerages have also issued reports on VKTX. Raymond James raised their price target on […] ....

San Diego , United States , Stifel Nicolaus , Marianna Mancini , Michaela Dinerman , Raymond James , Securities Exchange Commission , Marshall Wace , Therapeutics Inc , Boxer Capital , Renaissance Technologies , Maxim Group , Viking Therapeutics , Get Rating , Moderate Buy , Exchange Commission , Capital Management , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Boost Price Target ,

Viking Therapeutics (NASDAQ:VKTX) PT Raised to $25.00

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price raised by equities research analysts at Stifel Nicolaus from $22.00 to $25.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Stifel Nicolaus’ target price points to a potential upside of 56.94% from […] ....

San Diego , United States , Raymond James , Stifel Nicolaus , Stifel Nicolau , Michaela Dinerman , Therapeutics Inc , Steward Partners Investment Advisory , Global Investors , Morgan Stanley , Schonfeld Strategic Advisors , Chartwell Investment Partners , Viking Therapeutics , Get Rating , Truist Financial , Investment Partners , Partners Investment Advisory , Strategic Advisors , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Boost Price Target ,

Weekly Investment Analysts' Ratings Updates for Viking Therapeutics (VKTX)

Several brokerages have updated their recommendations and price targets on shares of Viking Therapeutics (NASDAQ: VKTX) in the last few weeks: 3/29/2023 – Viking Therapeutics had its price target raised by analysts at Raymond James from $12.00 to $35.00. They now have an “outperform” rating on the stock. 3/29/2023 – Viking Therapeutics had its price […] ....

San Diego , United States , Roth Mkm , Michaela Dinerman , Stifel Nicolaus , Raymond James , Connor Clark Lunn Investment Management Ltd , Financial Insights Inc , Maxim Group , Asset Management Corp , Therapeutics Inc , Truist Financial Co , Cornerstone Capital Inc , Oppenheimer Holdings Inc , News Ratings For Viking Therapeutics Inc Daily , Viking Therapeutics , Truist Financial , Oppenheimer Holdings , Get Rating , Capital Management , Management Corp , Connor Clark , Lunn Investment Management , Brian Lian , Viking Therapeutics Inc Daily , Viking Therapeutics Inc ,

Viking Therapeutics (NASDAQ:VKTX) Trading Up 6%

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating)’s share price was up 6% during trading on Monday . The company traded as high as $9.47 and last traded at $9.38. Approximately 480,074 shares changed hands during trading, a decline of 77% from the average daily volume of 2,130,222 shares. The stock had previously closed at $8.85. […] ....

San Diego , United States , Michaela Dinerman , Stifel Nicolaus , Raymond James , Therapeutics Inc , Therapeutics Company Profile , Brinker Capital Investments , Herr Investment Group , Maxim Group , Steward Partners Investment Advisory , Sg Americas Securities , Viking Therapeutics , Get Rating , Capital Investments , Investment Group , Partners Investment Advisory , Centiva Capital , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx ,